IRCT20190714044201N1 IRCT 2019-09-15 Sarem Fertility and Infertility Research Center Safety and efficacy of Amniotic Membrane in Asherman's syndrome management Safety and efficacy of Amniotic Membrane in Asherman's syndrome management 2019-07-11 anticipated 10 Complete https://irct.ir/trial/40801 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 2 Asherman's Syndrome. Patients with Asherman syndrome After Hysteroscopy and adhesions release, the amniotic membrane is placed on the uterine balloon stent and inserted into the uterus. Then 5cc normal saline is injected into the balloon.. No - There is not a plan to make this available Justification or reason for not sharing IPD is Ethical issue